SlideShare uma empresa Scribd logo
1 de 38
Baixar para ler offline
SHOVELING UP II: THE
IMPACT OF SUBSTANCE
ABUSE ON FEDERAL,
STATE AND LOCAL
BUDGETS
A Report by
CASAColumbia®
May 2009
Purpose of Study
• Update CASAColumbia’s 2001 report Shoveling Up: The Impact of
Substance Abuse on State Budgets
• Expand analysis to federal and local governments
• Differentiate spending by:
 The burden to public programs (crime, illness, social ills)
 The familiar categories of spending (prevention/treatment/research,
taxation/regulation, interdiction)

• Show promising practices for cost-effective investments

© CASAColumbia 2013

2
Advisory Panel
•

Frederick M. Bohen, Chairman, The Rockefeller University (retired)

•

Hon. Jeffrion L. Aubry, NYS Assemblyman, 35th Assembly District

•

Tom Cochran, US Conference of Mayors (Ed Somers, alternate)

•

Timothy P. Condon, PhD, National Institute on Drug Abuse (federal liaison)

•

Cabell Cropper, National Criminal Justice Association

•

Ester Fuchs, PhD, Columbia University, School of International and Public Affairs

•

Lewis E. Gallant, PhD, National Association of State Alcohol and Drug Abuse
Directors (retired)

•

Kristine Gebbie, DrPH, RN, School of Nursing, Hunter College, City University of
New York
© CASAColumbia 2013

3
Advisory Panel, cont.
•

Peter A. Harkness, Governing Magazine

•

Nolan E. Jones, PhD, National Governors Association (retired)

•

Larry Naake, National Association of Counties (Jackie Byers, alternate)

•

Scott Pattison, National Association of State Budget Officers

•

William T. Pound, National Conference of State Legislatures

•

Dorothy P. Rice, ScD, University of California, Institute on Health and Aging (retired)

•

Don Stapley, Maricopa County Board of Supervisors

•

Julie Boatright Wilson, PhD, Harvard University, John F. Kennedy School of
Government
© CASAColumbia 2013

4
Methodology
• Analyzed federal budget
• Surveyed states, DC and Puerto Rico; 47 respondents

• Analyzed total local expenditures (U.S. Census data)
• Case studies of a city government (Nashville,TN), a county
government (Multnomah,OR) and combined city-county
governments (Charlotte and Mecklenburg Co., NC)
• Reviewed > 900 articles/publications

© CASAColumbia 2013

5
Federal, state and local governments spent

$467.7 billion in 2005

on substance abuse and addiction,

10.7 % of total spending

© CASAColumbia 2013

6
Spending on Substance Abuse
and Addiction (2005)
• Federal: $238.2 billion (9.6% of budget)
• State: $135.8 billion (15.7% of budget)

• Local: $93.8 billion (9.0% of budget)

© CASAColumbia 2013

7
Coping With the Consequences
95.6% of Federal and State Substance-Related
Spending Is on the Burden to Public Programs
•
•
•
•
•
•
•
•
•
•
•
© CASAColumbia 2013

Adult Corrections
Juvenile Justice
Courts
Health Care
Elementary and Secondary Education
Income Support
Child Welfare
Mental Health
Developmental Disabilities
Public Safety
Workforce

8
Little Spent on
Prevention/Treatment
4.4% of Federal and State Substance-Related Spending
Is in the Familiar Categories of:
•
•

Treatment

•

Research

•

Regulation and Compliance

•

© CASAColumbia 2013

Prevention

Interdiction

9
The Substance Abuse/Addiction
Dollar
Of every Federal and State $ spent in 2005:
Research
0.4 cents
Prevention/Treatment
1.9 cents

Regulation/Compliance
1.4 cents
Interdiction
0.7 cents

Burden to Public
Programs
95.6 cents

Of every dollar federal and state governments spent on prevention and treatment, they spent $59.83 in public
programs shoveling up the wreckage of alcohol, tobacco and other drugs--despite evidence of cost-effective sciencebased interventions.
© CASAColumbia 2013

10
Conservative Estimates
•

Examples of costs unavailable due to data limits:
 Higher education

 Tobacco/drug-related developmental disabilities
 Drug-related highway accidents
 Civil court costs
 Many local government costs

© CASAColumbia 2013

11
Total Spending
If spending on substance abuse and addiction were its
own budget category:
• It would rank 2nd at the state level, behind elementary and
secondary education
• It would rank 6th at the federal level, behind social security, national
defense, income security, Medicare and other health programs
including the federal share of Medicaid

© CASAColumbia 2013

12
Spending just on the burden of
substance abuse and addiction takes
at least $1,486 each year from every
man, woman and child in America-$5,944 from a family of four

© CASAColumbia 2013

13
Greatest Burden in Two Areas
Of Federal and State 2005
Burden Spending of $357.4 billion,
71.1% Is in Health Care and Justice System Costs
• 58.0% of burden is in health care costs – substance abuse and
addiction that cause or contribute to more than 70 other diseases
requiring hospitalization
• 13.1% of burden is in justice system costs – substance abuse that
drives crime, incarceration and recidivism

© CASAColumbia 2013

14
Federal Burden Spending
Burden of Substance Abuse and Addiction on
Federal Programs by Budget Sector (Percent)
Total = $229.9 Billion
Mental Health/
Developmental
Disabilities
1.6

Public Safety
3.3

Federal
Workforce
0.4

Justice
System
2.4

Child/Family
Assistance
16.0
Education
2.4
Health Care
74.1

© CASAColumbia 2013

15
State Burden Spending
Burden of Substance Abuse and Addiction on
State Programs by Budget Sector (Percent)
Total = $127.5 Billion
Mental Health/
Developmental
Disabilities
6.4
Child/Family
Assistance
7.8

Public Safety
1.4

Federal
Workforce
0.5
Justice
System
32.5

Education
22.4
Health Care
29.0

© CASAColumbia 2013

16
Local Burden Spending
Burden of Substance Abuse and Addiction on
Local Programs by Budget Sector (Percent)
Total = $93.3 Billion
Public Safety
13.7

Local
Workforce
1.5
Justice
System
29.2

Child/Family
Assistance
8.2

Education
24.4%
Health Care
23.0
© CASAColumbia 2013

17
Federal and State Burden
Spending (2005)
Health Care
Justice System
Child/Family Assistance
Education
Mental Health/DD
Public Safety
Workforce
TOTAL

© CASAColumbia 2013

($ millions)
207,222
46,977
46,696
33,896
11,772
9,303
1,568
357,433

18
Other Federal and State
Spending (2005)
Little Spent in Familiar Substance Abuse
and Addiction Categories:
Prevention and Treatment

($ millions)
7,173

Research

1,604

Regulation and Compliance

5,066

Interdiction

2,638

TOTAL
© CASAColumbia 2013

16,481

19
Sin Taxes Don’t Pay Their Way
For each $ federal and state governments collect in alcohol and
tobacco taxes and liquor store revenues, they spend $8.95 shoveling
up the consequences

• The public health goal of tobacco taxes: eliminate use
• The public health goal of alcohol taxes: limit underage and adult
excessive drinking

© CASAColumbia 2013

20
For Every $100 Spent
On Substance Abuse and Addiction

Government

Prevention, Treatment
and Research

Federal

$ 2.33

State Average

$ 2.38

Wide Variation:
Connecticut

$10.39

Kentucky
Hawaii

$ 7.32
$ 0.55

New Hampshire

$ 0.22

© CASAColumbia 2013

21
RECOMMENDATIONS
• Prevention
• Treatment/Disease Management

• Taxation and Regulation
• Research

© CASAColumbia 2013

22
Prevent It!
• Public health information campaign
• Comprehensive messages and programs aimed at children

• Screenings, brief interventions and treatment referrals

© CASAColumbia 2013

23
Treat It!
• Comprehensive assessments
• Behavioral and pharmacological treatments

• Treatments for co-occurring disorders
• Long term disease management
• Drug treatment alternatives to prison and prison-based treatment
and aftercare
• Health insurance coverage for addiction prevention and treatments

© CASAColumbia 2013

24
Control It!
• Alcohol and tobacco tax increases
• Indoor smoking bans and tobacco quit lines

• Increased enforcement to limit youth access to tobacco and alcohol

© CASAColumbia 2013

25
Understand It!
• Increased genetic, biological and behavioral research
• Best practices

• Cost/benefit studies

© CASAColumbia 2013

26
Addiction is a disease that should be prevented
and treated--rather than waiting for the disease
to advance, cause enormous human suffering
and drive up health care, corrections and other
social costs

© CASAColumbia 2013

27
Ending Addiction
Changes Everything

www.casacolumbia.org

© CASAColumbia 2013
Speaker Notes
Slide 1:
•

This is the first study ever conducted documenting the costs of substance abuse and addiction to
all levels of government.

Slide 2:
•
•
•

•

This report is an update of CASAColumbia’s 2001 report of the same name that documented
costs of substance abuse to state governments.
This study was conducted in response to multiple requests from the states for updated state data.
We also extended the analysis to the federal and local levels.
This report breaks down substance related spending to look at:
1. How much goes to carry the burden of substance abuse and addiction in public programs.
By burden we mean the costs that governments incur to deal with the consequences of our
failure to prevent or treat the problem--consequences that drive up costs, for example, of
health care, crime, child neglect and abuse, and even workforce spending.
2. And how much of it goes to the familiar categories of substance related spending:
prevention, treatment, research, taxation, regulation, and drug interdiction.
Finally, the report identifies many promising and cost effective investment options.

Slide 6:
•

Of the $4.4 trillion in total federal, state and local government spending in 2005, at least $467.7
billion (10.7% of total spending) went to deal with substance abuse and addiction.
© CASAColumbia 2013

29
Speaker Notes
Slide 8:
•

The most shocking finding is that 95.6% of total substance-related federal and state spending
goes to shovel up the burden of this health problem in the budget categories you see here.

Slide 9:
•
•

Only 4.4% of state and federal spending is divided among these more familiar categories.
This report is a searing indictment of the policies of government at every level that spend virtually
all of the funds in this area to shovel up the wreckage of substance abuse and addiction and
relatively little to prevent and treat it.

Slide 10:
•
•

Here you can see how the burden to public programs at the federal and state level consumes our
resources.
Less than 2 cents of every substance abuse dollar goes to prevention and treatment, despite
extensive evidence of cost-effective strategies.

© CASAColumbia 2013

30
Speaker Notes
Slide 11:
•
•
•
•

Despite the enormity of spending in this area, these estimates are in every measure conservative:
In cases where our data were limited, we always chose the conservative estimate.
In some areas, such as you see here, we were not able to make any estimates due to data
limitations.
The true costs to government are likely much higher than our estimates suggest.

Slide 12:
•

Even with these conservative assumptions,
• If spending on tobacco, alcohol and other drugs were its own state budget category, it would
rank second, surpassed only by state spending on elementary and secondary education.
• At the federal level, it would rank 6th behind the big ticket items like social security, national
defense and health.

Slide 13:
•

Total government substance-related spending on the burden to public programs amounts to an
average of $1,486 each year for every person in America--almost $6,000 for a family of 4.

© CASAColumbia 2013

31
Speaker Notes
Slide 14:
•
•

Two areas of spending on the burden of substance abuse and addiction to government comprise
almost 3/4 of federal and state burden spending: health care and the justice system.
The largest share is the impact on health spending where untreated addiction drives
hospitalizations for more than 70 other diseases.

Slide 15:
•
•
•

•

With these next 3 slides, you will see how the burden to public programs is distributed at each
level of government.
This is the 95.6 cents of every substance abuse dollar.
At the federal level, spending on the burden of this disease in our health care programs consumes
74% of federal burden spending.
The next largest category is child and family assistance--welfare and services for children who are
neglected and abused.

Slide 16:
•
•

At the state level, justice system spending makes up the largest share of the burden,
Followed closely by health care and the cost of substance abuse to the education system—such
as special education for those with substance-related learning disabilities or mental retardation.

© CASAColumbia 2013

32
Speaker Notes
Slide 17:
•
•

As with the states, substance-related justice spending is the largest share of local burden
spending.
Substance-related education spending comes in second locally, followed closely by health care.

Slide 18:
•
•

Here is a summary of how the federal and state burden spending breaks out by category.
Health care spending dwarfs all other categories.

Slide 19:
•

Here is the same information for the remaining categories of spending.

© CASAColumbia 2013

33
Speaker Notes
Slide 20:
•
•

Tobacco and alcohol taxes reduce use and provide much needed government revenues--but
these taxes don’t begin to offset the burden substance abuse imposes.
For each dollar federal and state governments receive in tobacco and alcohol taxes and liquor
store revenues, they pay almost $9 on the burden of substance abuse.

Slide 21:
•
•

•

Even though spending on prevention, treatment and research is very low, there are wide
variations among the states.
For every $100 in substance-related spending,
• The federal government spends $2.33 on prevention, treatment and research
• And states spend on average about the same--$2.38
But spending ranges from a low of:
• $0.22 in New Hampshire
• To a high of $10.39 in Connecticut

© CASAColumbia 2013

34
Speaker Notes
Slide 22:
•
•

There is much more detail in the report on substance-related spending by jurisdiction, and a wide
range of recommendations.
Key recommendations are designed to reverse our upside down spending patterns.

Slide 23:
•
•
•

Prevention is a top priority and the main focus of our prevention efforts must be our children.
Prevention strategies should include broad-based public health information campaigns to:
• Increase public understanding about addiction, and
• Change the culture around alcohol and other drug use as we have done with tobacco.
Examples are:
• Targeted media campaigns like the Legacy’s truth campaign
• Comprehensive school and community-based programs
• And screenings and brief interventions in many different venues to look for the problem and
intervene early before the disease and its cost progress.

© CASAColumbia 2013

35
Speaker Notes
Slide 24:
•
•
•

•
•

Effective evidence-based treatment is critical.
Approximately 9% of the population suffers from an addictive disorder, but only about 10% of them
receive treatment--lower than for any other health condition.
Treatment includes:
• Behavioral and pharmacological approaches
• Treatment for mental and other health disorders that co-occur with addiction
• And long term disease management as would be provided for diabetes and hypertension, for
example.
Health insurance coverage for early intervention and treatment, as we do with other chronic
diseases, is essential--as is expanded coverage for the uninsured.
A review of the cost-related research on treatment by the National Institute on Drug Abuse found
that investments in treatment alone could yield a savings of $12 or more for every dollar invested.

© CASAColumbia 2013

36
Speaker Notes
Slide 25:
•
•
•

•

We need to do a better job of regulation and control.
Taxation on tobacco can help reduce smoking and on alcohol can curb both underage and adult
excessive drinking.
Raising alcohol and tobacco taxes also are linked to immediate health and cost benefits as are
indoor smoking bans
And increased enforcement can help keep these substances out of the hands of children and
teens.

Slide 26:
•

We need to increase our knowledge about the disease of addiction and more cost-effective
prevention and treatment options.

© CASAColumbia 2013

37
Speaker Notes
Slide 27:
•
•

•

•

Medical science has demonstrated that addiction is a disease that can and should be prevented
and treated. America’s failure to recognize this fact has resulted in untold and avoidable human
suffering as well as the billions in wasted spending this report has uncovered.
The findings of this report suggest a huge opportunity for costs savings--savings that are
particularly crucial in these times of tight budget constraints. The shifts in investments we
recommend do not all require new money. We need to change the way we do business--for
example, paying for treatment and training instead of simply incarceration.
Because there is no broad-based implementation plan in place, we can’t put a definitive price on
expected savings. We do know, though, that specific interventions can yield significant returns in a
short period. For example:
• Screenings and brief interventions can reduce hospitalizations by up to 37% and ER visits by
up to 20% in a year
• Treatment can reduce alcohol- or other drug-related medical visits by more than 1/2 in a year
• A 10% increase in cigarette taxes can reduce youth smoking by 6-7%.
And we know that the impact is likely compounded as more and more interventions are taken to
scale.

© CASAColumbia 2013

38

Mais conteúdo relacionado

Mais procurados

Rx16 heroin wed_330_1_rader_2lynch-earle
Rx16 heroin wed_330_1_rader_2lynch-earleRx16 heroin wed_330_1_rader_2lynch-earle
Rx16 heroin wed_330_1_rader_2lynch-earleOPUNITE
 
Integration of Behavioral and Primary Care
Integration of Behavioral and Primary CareIntegration of Behavioral and Primary Care
Integration of Behavioral and Primary CareMatthew Dunning
 
Rx16 prevent wed_200_1_cairnes-wertnepy_2arnold
Rx16 prevent wed_200_1_cairnes-wertnepy_2arnoldRx16 prevent wed_200_1_cairnes-wertnepy_2arnold
Rx16 prevent wed_200_1_cairnes-wertnepy_2arnoldOPUNITE
 
Rx16 len wed_330_1_ferdinand_2price
Rx16 len wed_330_1_ferdinand_2priceRx16 len wed_330_1_ferdinand_2price
Rx16 len wed_330_1_ferdinand_2priceOPUNITE
 
Rx16 heroin wed_200_1_parker-daley_2guarino-luongo_3taylor
Rx16 heroin wed_200_1_parker-daley_2guarino-luongo_3taylorRx16 heroin wed_200_1_parker-daley_2guarino-luongo_3taylor
Rx16 heroin wed_200_1_parker-daley_2guarino-luongo_3taylorOPUNITE
 
Rx16 prev wed_330_workplace issues and strategies
Rx16 prev wed_330_workplace issues and strategiesRx16 prev wed_330_workplace issues and strategies
Rx16 prev wed_330_workplace issues and strategiesOPUNITE
 
Rx16 heroin tues_330_1_moser_2proescholdbell-sachdeva
Rx16 heroin tues_330_1_moser_2proescholdbell-sachdevaRx16 heroin tues_330_1_moser_2proescholdbell-sachdeva
Rx16 heroin tues_330_1_moser_2proescholdbell-sachdevaOPUNITE
 
Rx16 prev wed_1115_1_napier_2justice_3phillips_4sturgeon
Rx16 prev wed_1115_1_napier_2justice_3phillips_4sturgeonRx16 prev wed_1115_1_napier_2justice_3phillips_4sturgeon
Rx16 prev wed_1115_1_napier_2justice_3phillips_4sturgeonOPUNITE
 
Rx16 adv wed_1230_1_thau_2gorman
Rx16 adv wed_1230_1_thau_2gormanRx16 adv wed_1230_1_thau_2gorman
Rx16 adv wed_1230_1_thau_2gormanOPUNITE
 
Rx16 treat tues_330_1_mcneely_2d_onofrio_3macdonald
Rx16 treat tues_330_1_mcneely_2d_onofrio_3macdonaldRx16 treat tues_330_1_mcneely_2d_onofrio_3macdonald
Rx16 treat tues_330_1_mcneely_2d_onofrio_3macdonaldOPUNITE
 
Mental Health Policy - The Affordablle Care Act and Mental Health
Mental Health Policy - The Affordablle Care Act and Mental HealthMental Health Policy - The Affordablle Care Act and Mental Health
Mental Health Policy - The Affordablle Care Act and Mental HealthDr. James Swartz
 
Rx16 clinical tues_200_1_samuels_2waller_3_lynch_4earle
Rx16 clinical tues_200_1_samuels_2waller_3_lynch_4earleRx16 clinical tues_200_1_samuels_2waller_3_lynch_4earle
Rx16 clinical tues_200_1_samuels_2waller_3_lynch_4earleOPUNITE
 
Rx16 len tues_200_1_beshear_2ohr-menendez
Rx16 len tues_200_1_beshear_2ohr-menendezRx16 len tues_200_1_beshear_2ohr-menendez
Rx16 len tues_200_1_beshear_2ohr-menendezOPUNITE
 
Web only rx16 pharma-wed_330_1_shelley_2atwood-harless
Web only rx16 pharma-wed_330_1_shelley_2atwood-harlessWeb only rx16 pharma-wed_330_1_shelley_2atwood-harless
Web only rx16 pharma-wed_330_1_shelley_2atwood-harlessOPUNITE
 
How brief can you go a history of ib as and brief literature review (2)
How brief can you go a history of ib as and brief literature review (2)How brief can you go a history of ib as and brief literature review (2)
How brief can you go a history of ib as and brief literature review (2)Centre for Public Health
 
Rx16 heroin tues_200_1_allen-harocopos_2willis
Rx16 heroin tues_200_1_allen-harocopos_2willisRx16 heroin tues_200_1_allen-harocopos_2willis
Rx16 heroin tues_200_1_allen-harocopos_2willisOPUNITE
 
Evidence based guidelines: chronic harms of substance use
Evidence based guidelines: chronic harms of substance useEvidence based guidelines: chronic harms of substance use
Evidence based guidelines: chronic harms of substance useWorkingwithsubstanceabuse
 
Accomodation and prevention substance abuse
Accomodation and prevention substance abuse Accomodation and prevention substance abuse
Accomodation and prevention substance abuse CG Hylton Inc.
 

Mais procurados (20)

Rx16 heroin wed_330_1_rader_2lynch-earle
Rx16 heroin wed_330_1_rader_2lynch-earleRx16 heroin wed_330_1_rader_2lynch-earle
Rx16 heroin wed_330_1_rader_2lynch-earle
 
Integration of Behavioral and Primary Care
Integration of Behavioral and Primary CareIntegration of Behavioral and Primary Care
Integration of Behavioral and Primary Care
 
Cannabis for Harm Reduction
Cannabis for Harm ReductionCannabis for Harm Reduction
Cannabis for Harm Reduction
 
Rx16 prevent wed_200_1_cairnes-wertnepy_2arnold
Rx16 prevent wed_200_1_cairnes-wertnepy_2arnoldRx16 prevent wed_200_1_cairnes-wertnepy_2arnold
Rx16 prevent wed_200_1_cairnes-wertnepy_2arnold
 
Rx16 len wed_330_1_ferdinand_2price
Rx16 len wed_330_1_ferdinand_2priceRx16 len wed_330_1_ferdinand_2price
Rx16 len wed_330_1_ferdinand_2price
 
Rx16 heroin wed_200_1_parker-daley_2guarino-luongo_3taylor
Rx16 heroin wed_200_1_parker-daley_2guarino-luongo_3taylorRx16 heroin wed_200_1_parker-daley_2guarino-luongo_3taylor
Rx16 heroin wed_200_1_parker-daley_2guarino-luongo_3taylor
 
Rx16 prev wed_330_workplace issues and strategies
Rx16 prev wed_330_workplace issues and strategiesRx16 prev wed_330_workplace issues and strategies
Rx16 prev wed_330_workplace issues and strategies
 
Rx16 heroin tues_330_1_moser_2proescholdbell-sachdeva
Rx16 heroin tues_330_1_moser_2proescholdbell-sachdevaRx16 heroin tues_330_1_moser_2proescholdbell-sachdeva
Rx16 heroin tues_330_1_moser_2proescholdbell-sachdeva
 
Rx16 prev wed_1115_1_napier_2justice_3phillips_4sturgeon
Rx16 prev wed_1115_1_napier_2justice_3phillips_4sturgeonRx16 prev wed_1115_1_napier_2justice_3phillips_4sturgeon
Rx16 prev wed_1115_1_napier_2justice_3phillips_4sturgeon
 
Rx16 adv wed_1230_1_thau_2gorman
Rx16 adv wed_1230_1_thau_2gormanRx16 adv wed_1230_1_thau_2gorman
Rx16 adv wed_1230_1_thau_2gorman
 
Rx16 treat tues_330_1_mcneely_2d_onofrio_3macdonald
Rx16 treat tues_330_1_mcneely_2d_onofrio_3macdonaldRx16 treat tues_330_1_mcneely_2d_onofrio_3macdonald
Rx16 treat tues_330_1_mcneely_2d_onofrio_3macdonald
 
Mental Health Policy - The Affordablle Care Act and Mental Health
Mental Health Policy - The Affordablle Care Act and Mental HealthMental Health Policy - The Affordablle Care Act and Mental Health
Mental Health Policy - The Affordablle Care Act and Mental Health
 
Rx16 clinical tues_200_1_samuels_2waller_3_lynch_4earle
Rx16 clinical tues_200_1_samuels_2waller_3_lynch_4earleRx16 clinical tues_200_1_samuels_2waller_3_lynch_4earle
Rx16 clinical tues_200_1_samuels_2waller_3_lynch_4earle
 
Rx16 len tues_200_1_beshear_2ohr-menendez
Rx16 len tues_200_1_beshear_2ohr-menendezRx16 len tues_200_1_beshear_2ohr-menendez
Rx16 len tues_200_1_beshear_2ohr-menendez
 
Web only rx16 pharma-wed_330_1_shelley_2atwood-harless
Web only rx16 pharma-wed_330_1_shelley_2atwood-harlessWeb only rx16 pharma-wed_330_1_shelley_2atwood-harless
Web only rx16 pharma-wed_330_1_shelley_2atwood-harless
 
Treatment
TreatmentTreatment
Treatment
 
How brief can you go a history of ib as and brief literature review (2)
How brief can you go a history of ib as and brief literature review (2)How brief can you go a history of ib as and brief literature review (2)
How brief can you go a history of ib as and brief literature review (2)
 
Rx16 heroin tues_200_1_allen-harocopos_2willis
Rx16 heroin tues_200_1_allen-harocopos_2willisRx16 heroin tues_200_1_allen-harocopos_2willis
Rx16 heroin tues_200_1_allen-harocopos_2willis
 
Evidence based guidelines: chronic harms of substance use
Evidence based guidelines: chronic harms of substance useEvidence based guidelines: chronic harms of substance use
Evidence based guidelines: chronic harms of substance use
 
Accomodation and prevention substance abuse
Accomodation and prevention substance abuse Accomodation and prevention substance abuse
Accomodation and prevention substance abuse
 

Destaque

Behind Bars II: Substance Use and America’s Prison Population
Behind Bars II: Substance Use and America’s Prison PopulationBehind Bars II: Substance Use and America’s Prison Population
Behind Bars II: Substance Use and America’s Prison PopulationCenter on Addiction
 
National Survey of American Attitudes on Substance Abuse XVII: Teens
National Survey of American Attitudes on Substance Abuse XVII: TeensNational Survey of American Attitudes on Substance Abuse XVII: Teens
National Survey of American Attitudes on Substance Abuse XVII: TeensCenter on Addiction
 
Adolescent Substance Use: America’s #1 Public Health Problem
Adolescent Substance Use: America’s #1 Public Health ProblemAdolescent Substance Use: America’s #1 Public Health Problem
Adolescent Substance Use: America’s #1 Public Health Problem Center on Addiction
 
Does family therapy for adolescent behavior problems work in the real world
Does family therapy for adolescent behavior problems work in the real worldDoes family therapy for adolescent behavior problems work in the real world
Does family therapy for adolescent behavior problems work in the real worldCenter on Addiction
 
Understanding And Addressing Nicotine Addiction: A Science-Based Approach to ...
Understanding And Addressing Nicotine Addiction: A Science-Based Approach to ...Understanding And Addressing Nicotine Addiction: A Science-Based Approach to ...
Understanding And Addressing Nicotine Addiction: A Science-Based Approach to ...Center on Addiction
 
The economic burden of prescription opioid overdose... 2013.
The economic burden of prescription opioid overdose... 2013.The economic burden of prescription opioid overdose... 2013.
The economic burden of prescription opioid overdose... 2013.Paul Coelho, MD
 
Neurobiology and Treatment of Alcohol Withdrawal
Neurobiology and Treatment of Alcohol Withdrawal Neurobiology and Treatment of Alcohol Withdrawal
Neurobiology and Treatment of Alcohol Withdrawal Andri Andri
 
Understanding and Addressing Food Addiction: A Science-Based Approach to Poli...
Understanding and Addressing Food Addiction: A Science-Based Approach to Poli...Understanding and Addressing Food Addiction: A Science-Based Approach to Poli...
Understanding and Addressing Food Addiction: A Science-Based Approach to Poli...Center on Addiction
 
Understanding Mechanisms of Behavior Change
Understanding Mechanisms of Behavior ChangeUnderstanding Mechanisms of Behavior Change
Understanding Mechanisms of Behavior ChangeCenter on Addiction
 
Substance Abuse and Addiction
Substance Abuse and AddictionSubstance Abuse and Addiction
Substance Abuse and AddictionRobin Victor
 
Overview of Medications to Treat Addiction in Primary Care
Overview of Medications to Treat Addiction in Primary CareOverview of Medications to Treat Addiction in Primary Care
Overview of Medications to Treat Addiction in Primary CareCenter on Addiction
 

Destaque (13)

Behind Bars II: Substance Use and America’s Prison Population
Behind Bars II: Substance Use and America’s Prison PopulationBehind Bars II: Substance Use and America’s Prison Population
Behind Bars II: Substance Use and America’s Prison Population
 
National Survey of American Attitudes on Substance Abuse XVII: Teens
National Survey of American Attitudes on Substance Abuse XVII: TeensNational Survey of American Attitudes on Substance Abuse XVII: Teens
National Survey of American Attitudes on Substance Abuse XVII: Teens
 
Adolescent Substance Use: America’s #1 Public Health Problem
Adolescent Substance Use: America’s #1 Public Health ProblemAdolescent Substance Use: America’s #1 Public Health Problem
Adolescent Substance Use: America’s #1 Public Health Problem
 
Does family therapy for adolescent behavior problems work in the real world
Does family therapy for adolescent behavior problems work in the real worldDoes family therapy for adolescent behavior problems work in the real world
Does family therapy for adolescent behavior problems work in the real world
 
ADHD in Adolescence
ADHD in AdolescenceADHD in Adolescence
ADHD in Adolescence
 
Understanding And Addressing Nicotine Addiction: A Science-Based Approach to ...
Understanding And Addressing Nicotine Addiction: A Science-Based Approach to ...Understanding And Addressing Nicotine Addiction: A Science-Based Approach to ...
Understanding And Addressing Nicotine Addiction: A Science-Based Approach to ...
 
The economic burden of prescription opioid overdose... 2013.
The economic burden of prescription opioid overdose... 2013.The economic burden of prescription opioid overdose... 2013.
The economic burden of prescription opioid overdose... 2013.
 
Neurobiology and Treatment of Alcohol Withdrawal
Neurobiology and Treatment of Alcohol Withdrawal Neurobiology and Treatment of Alcohol Withdrawal
Neurobiology and Treatment of Alcohol Withdrawal
 
Understanding and Addressing Food Addiction: A Science-Based Approach to Poli...
Understanding and Addressing Food Addiction: A Science-Based Approach to Poli...Understanding and Addressing Food Addiction: A Science-Based Approach to Poli...
Understanding and Addressing Food Addiction: A Science-Based Approach to Poli...
 
Understanding Mechanisms of Behavior Change
Understanding Mechanisms of Behavior ChangeUnderstanding Mechanisms of Behavior Change
Understanding Mechanisms of Behavior Change
 
Substance Abuse and Addiction
Substance Abuse and AddictionSubstance Abuse and Addiction
Substance Abuse and Addiction
 
Overview of Medications to Treat Addiction in Primary Care
Overview of Medications to Treat Addiction in Primary CareOverview of Medications to Treat Addiction in Primary Care
Overview of Medications to Treat Addiction in Primary Care
 
How to write a statement problem
How to write a statement problemHow to write a statement problem
How to write a statement problem
 

Semelhante a Shoveling Up II: The Impact of Substance Abuse on Federal, State and Local Budgets

Prevention SPL The Determinators Final 8-16-2012_201302011043123860.pptx
Prevention SPL The Determinators Final 8-16-2012_201302011043123860.pptxPrevention SPL The Determinators Final 8-16-2012_201302011043123860.pptx
Prevention SPL The Determinators Final 8-16-2012_201302011043123860.pptxJanetOdhiambo2
 
Jasper Social Touching Class Data SP18 (1).savstatistics.jnl.docx
Jasper Social Touching Class Data SP18 (1).savstatistics.jnl.docxJasper Social Touching Class Data SP18 (1).savstatistics.jnl.docx
Jasper Social Touching Class Data SP18 (1).savstatistics.jnl.docxchristiandean12115
 
Community Care Based Services
Community Care Based ServicesCommunity Care Based Services
Community Care Based ServicesGilbert Gonzales
 
State of tobacco control in Nebraska 04 20-11 2
State of tobacco control in Nebraska 04 20-11 2State of tobacco control in Nebraska 04 20-11 2
State of tobacco control in Nebraska 04 20-11 2Cindy Jeffrey
 
Nur512 tobacco prevention and control (1)
Nur512 tobacco prevention and control (1)Nur512 tobacco prevention and control (1)
Nur512 tobacco prevention and control (1)Lynne Mahaffey
 
Human rights watch scpg presentation 11.10.11
Human rights watch scpg presentation 11.10.11Human rights watch scpg presentation 11.10.11
Human rights watch scpg presentation 11.10.11mellarocomolter
 
Tuesday astho
Tuesday asthoTuesday astho
Tuesday asthoOPUNITE
 
Substance Abuse Prevention in Snohomish County, WA
Substance Abuse Prevention in Snohomish County, WASubstance Abuse Prevention in Snohomish County, WA
Substance Abuse Prevention in Snohomish County, WAMonroe Community Coalition
 
Alcohol and Public Health CDC presentation
Alcohol and Public Health CDC presentationAlcohol and Public Health CDC presentation
Alcohol and Public Health CDC presentationponced
 
The National HIV Prevention Inventory Final
The National HIV Prevention Inventory FinalThe National HIV Prevention Inventory Final
The National HIV Prevention Inventory FinalNASTAD
 
Rx15 vision wed_200_oig
Rx15 vision wed_200_oigRx15 vision wed_200_oig
Rx15 vision wed_200_oigOPUNITE
 
Prescription drugs first do no harm update
Prescription drugs first do no harm updatePrescription drugs first do no harm update
Prescription drugs first do no harm updateNNAPF_web
 
Muska and Abbott Behavioral Health Report
Muska and Abbott Behavioral Health ReportMuska and Abbott Behavioral Health Report
Muska and Abbott Behavioral Health ReportChristopher Abbott
 

Semelhante a Shoveling Up II: The Impact of Substance Abuse on Federal, State and Local Budgets (20)

Prevention SPL The Determinators Final 8-16-2012_201302011043123860.pptx
Prevention SPL The Determinators Final 8-16-2012_201302011043123860.pptxPrevention SPL The Determinators Final 8-16-2012_201302011043123860.pptx
Prevention SPL The Determinators Final 8-16-2012_201302011043123860.pptx
 
Jasper Social Touching Class Data SP18 (1).savstatistics.jnl.docx
Jasper Social Touching Class Data SP18 (1).savstatistics.jnl.docxJasper Social Touching Class Data SP18 (1).savstatistics.jnl.docx
Jasper Social Touching Class Data SP18 (1).savstatistics.jnl.docx
 
Community Care Based Services
Community Care Based ServicesCommunity Care Based Services
Community Care Based Services
 
Federal tobacco control
Federal tobacco controlFederal tobacco control
Federal tobacco control
 
Tobacco Winnable Battle presentation
Tobacco Winnable Battle presentationTobacco Winnable Battle presentation
Tobacco Winnable Battle presentation
 
Tobacco wb webinar 5 1-12
Tobacco wb webinar 5 1-12Tobacco wb webinar 5 1-12
Tobacco wb webinar 5 1-12
 
State of tobacco control in Nebraska 04 20-11 2
State of tobacco control in Nebraska 04 20-11 2State of tobacco control in Nebraska 04 20-11 2
State of tobacco control in Nebraska 04 20-11 2
 
The Domino Effect
The Domino EffectThe Domino Effect
The Domino Effect
 
Nur512 tobacco prevention and control (1)
Nur512 tobacco prevention and control (1)Nur512 tobacco prevention and control (1)
Nur512 tobacco prevention and control (1)
 
Human rights watch scpg presentation 11.10.11
Human rights watch scpg presentation 11.10.11Human rights watch scpg presentation 11.10.11
Human rights watch scpg presentation 11.10.11
 
Tuesday astho
Tuesday asthoTuesday astho
Tuesday astho
 
Substance Abuse Prevention in Snohomish County, WA
Substance Abuse Prevention in Snohomish County, WASubstance Abuse Prevention in Snohomish County, WA
Substance Abuse Prevention in Snohomish County, WA
 
Alcohol and Public Health CDC presentation
Alcohol and Public Health CDC presentationAlcohol and Public Health CDC presentation
Alcohol and Public Health CDC presentation
 
The National HIV Prevention Inventory Final
The National HIV Prevention Inventory FinalThe National HIV Prevention Inventory Final
The National HIV Prevention Inventory Final
 
Rx15 vision wed_200_oig
Rx15 vision wed_200_oigRx15 vision wed_200_oig
Rx15 vision wed_200_oig
 
Epi workgroup feb 7 2019tg
Epi workgroup feb 7 2019tgEpi workgroup feb 7 2019tg
Epi workgroup feb 7 2019tg
 
Why states should fund comprehensive tc programs
Why states should fund comprehensive tc programsWhy states should fund comprehensive tc programs
Why states should fund comprehensive tc programs
 
Office Of Substance Abuse Prevention2
Office Of Substance Abuse Prevention2Office Of Substance Abuse Prevention2
Office Of Substance Abuse Prevention2
 
Prescription drugs first do no harm update
Prescription drugs first do no harm updatePrescription drugs first do no harm update
Prescription drugs first do no harm update
 
Muska and Abbott Behavioral Health Report
Muska and Abbott Behavioral Health ReportMuska and Abbott Behavioral Health Report
Muska and Abbott Behavioral Health Report
 

Último

Glomerular Filtration and determinants of glomerular filtration .pptx
Glomerular Filtration and  determinants of glomerular filtration .pptxGlomerular Filtration and  determinants of glomerular filtration .pptx
Glomerular Filtration and determinants of glomerular filtration .pptxDr.Nusrat Tariq
 
PNEUMOTHORAX AND ITS MANAGEMENTS.pdf
PNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdfPNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdf
PNEUMOTHORAX AND ITS MANAGEMENTS.pdfDolisha Warbi
 
Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...
Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...
Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...MehranMouzam
 
SWD (Short wave diathermy)- Physiotherapy.ppt
SWD (Short wave diathermy)- Physiotherapy.pptSWD (Short wave diathermy)- Physiotherapy.ppt
SWD (Short wave diathermy)- Physiotherapy.pptMumux Mirani
 
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdfLippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdfSreeja Cherukuru
 
Tans femoral Amputee : Prosthetics Knee Joints.pptx
Tans femoral Amputee : Prosthetics Knee Joints.pptxTans femoral Amputee : Prosthetics Knee Joints.pptx
Tans femoral Amputee : Prosthetics Knee Joints.pptxKezaiah S
 
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...Badalona Serveis Assistencials
 
Primary headache and facial pain. (2024)
Primary headache and facial pain. (2024)Primary headache and facial pain. (2024)
Primary headache and facial pain. (2024)Mohamed Rizk Khodair
 
Presentation on General Anesthetics pdf.
Presentation on General Anesthetics pdf.Presentation on General Anesthetics pdf.
Presentation on General Anesthetics pdf.Prerana Jadhav
 
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...Wessex Health Partners
 
Informed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptxInformed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptxSasikiranMarri
 
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara RajendranMusic Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara RajendranTara Rajendran
 
Clinical Pharmacotherapy of Scabies Disease
Clinical Pharmacotherapy of Scabies DiseaseClinical Pharmacotherapy of Scabies Disease
Clinical Pharmacotherapy of Scabies DiseaseSreenivasa Reddy Thalla
 
Case Report Peripartum Cardiomyopathy.pptx
Case Report Peripartum Cardiomyopathy.pptxCase Report Peripartum Cardiomyopathy.pptx
Case Report Peripartum Cardiomyopathy.pptxNiranjan Chavan
 
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptx
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptxPresentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptx
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptxpdamico1
 
Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...
Big Data Analysis Suggests COVID  Vaccination Increases Excess Mortality Of  ...Big Data Analysis Suggests COVID  Vaccination Increases Excess Mortality Of  ...
Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...sdateam0
 
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptx
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptxPERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptx
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptxdrashraf369
 
systemic bacteriology (7)............pptx
systemic bacteriology (7)............pptxsystemic bacteriology (7)............pptx
systemic bacteriology (7)............pptxEyobAlemu11
 
Biomechanics- Shoulder Joint!!!!!!!!!!!!
Biomechanics- Shoulder Joint!!!!!!!!!!!!Biomechanics- Shoulder Joint!!!!!!!!!!!!
Biomechanics- Shoulder Joint!!!!!!!!!!!!ibtesaam huma
 
Nutrition of OCD for my Nutritional Neuroscience Class
Nutrition of OCD for my Nutritional Neuroscience ClassNutrition of OCD for my Nutritional Neuroscience Class
Nutrition of OCD for my Nutritional Neuroscience Classmanuelazg2001
 

Último (20)

Glomerular Filtration and determinants of glomerular filtration .pptx
Glomerular Filtration and  determinants of glomerular filtration .pptxGlomerular Filtration and  determinants of glomerular filtration .pptx
Glomerular Filtration and determinants of glomerular filtration .pptx
 
PNEUMOTHORAX AND ITS MANAGEMENTS.pdf
PNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdfPNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdf
PNEUMOTHORAX AND ITS MANAGEMENTS.pdf
 
Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...
Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...
Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...
 
SWD (Short wave diathermy)- Physiotherapy.ppt
SWD (Short wave diathermy)- Physiotherapy.pptSWD (Short wave diathermy)- Physiotherapy.ppt
SWD (Short wave diathermy)- Physiotherapy.ppt
 
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdfLippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
 
Tans femoral Amputee : Prosthetics Knee Joints.pptx
Tans femoral Amputee : Prosthetics Knee Joints.pptxTans femoral Amputee : Prosthetics Knee Joints.pptx
Tans femoral Amputee : Prosthetics Knee Joints.pptx
 
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
 
Primary headache and facial pain. (2024)
Primary headache and facial pain. (2024)Primary headache and facial pain. (2024)
Primary headache and facial pain. (2024)
 
Presentation on General Anesthetics pdf.
Presentation on General Anesthetics pdf.Presentation on General Anesthetics pdf.
Presentation on General Anesthetics pdf.
 
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
 
Informed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptxInformed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptx
 
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara RajendranMusic Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
 
Clinical Pharmacotherapy of Scabies Disease
Clinical Pharmacotherapy of Scabies DiseaseClinical Pharmacotherapy of Scabies Disease
Clinical Pharmacotherapy of Scabies Disease
 
Case Report Peripartum Cardiomyopathy.pptx
Case Report Peripartum Cardiomyopathy.pptxCase Report Peripartum Cardiomyopathy.pptx
Case Report Peripartum Cardiomyopathy.pptx
 
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptx
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptxPresentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptx
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptx
 
Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...
Big Data Analysis Suggests COVID  Vaccination Increases Excess Mortality Of  ...Big Data Analysis Suggests COVID  Vaccination Increases Excess Mortality Of  ...
Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...
 
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptx
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptxPERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptx
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptx
 
systemic bacteriology (7)............pptx
systemic bacteriology (7)............pptxsystemic bacteriology (7)............pptx
systemic bacteriology (7)............pptx
 
Biomechanics- Shoulder Joint!!!!!!!!!!!!
Biomechanics- Shoulder Joint!!!!!!!!!!!!Biomechanics- Shoulder Joint!!!!!!!!!!!!
Biomechanics- Shoulder Joint!!!!!!!!!!!!
 
Nutrition of OCD for my Nutritional Neuroscience Class
Nutrition of OCD for my Nutritional Neuroscience ClassNutrition of OCD for my Nutritional Neuroscience Class
Nutrition of OCD for my Nutritional Neuroscience Class
 

Shoveling Up II: The Impact of Substance Abuse on Federal, State and Local Budgets

  • 1. SHOVELING UP II: THE IMPACT OF SUBSTANCE ABUSE ON FEDERAL, STATE AND LOCAL BUDGETS A Report by CASAColumbia® May 2009
  • 2. Purpose of Study • Update CASAColumbia’s 2001 report Shoveling Up: The Impact of Substance Abuse on State Budgets • Expand analysis to federal and local governments • Differentiate spending by:  The burden to public programs (crime, illness, social ills)  The familiar categories of spending (prevention/treatment/research, taxation/regulation, interdiction) • Show promising practices for cost-effective investments © CASAColumbia 2013 2
  • 3. Advisory Panel • Frederick M. Bohen, Chairman, The Rockefeller University (retired) • Hon. Jeffrion L. Aubry, NYS Assemblyman, 35th Assembly District • Tom Cochran, US Conference of Mayors (Ed Somers, alternate) • Timothy P. Condon, PhD, National Institute on Drug Abuse (federal liaison) • Cabell Cropper, National Criminal Justice Association • Ester Fuchs, PhD, Columbia University, School of International and Public Affairs • Lewis E. Gallant, PhD, National Association of State Alcohol and Drug Abuse Directors (retired) • Kristine Gebbie, DrPH, RN, School of Nursing, Hunter College, City University of New York © CASAColumbia 2013 3
  • 4. Advisory Panel, cont. • Peter A. Harkness, Governing Magazine • Nolan E. Jones, PhD, National Governors Association (retired) • Larry Naake, National Association of Counties (Jackie Byers, alternate) • Scott Pattison, National Association of State Budget Officers • William T. Pound, National Conference of State Legislatures • Dorothy P. Rice, ScD, University of California, Institute on Health and Aging (retired) • Don Stapley, Maricopa County Board of Supervisors • Julie Boatright Wilson, PhD, Harvard University, John F. Kennedy School of Government © CASAColumbia 2013 4
  • 5. Methodology • Analyzed federal budget • Surveyed states, DC and Puerto Rico; 47 respondents • Analyzed total local expenditures (U.S. Census data) • Case studies of a city government (Nashville,TN), a county government (Multnomah,OR) and combined city-county governments (Charlotte and Mecklenburg Co., NC) • Reviewed > 900 articles/publications © CASAColumbia 2013 5
  • 6. Federal, state and local governments spent $467.7 billion in 2005 on substance abuse and addiction, 10.7 % of total spending © CASAColumbia 2013 6
  • 7. Spending on Substance Abuse and Addiction (2005) • Federal: $238.2 billion (9.6% of budget) • State: $135.8 billion (15.7% of budget) • Local: $93.8 billion (9.0% of budget) © CASAColumbia 2013 7
  • 8. Coping With the Consequences 95.6% of Federal and State Substance-Related Spending Is on the Burden to Public Programs • • • • • • • • • • • © CASAColumbia 2013 Adult Corrections Juvenile Justice Courts Health Care Elementary and Secondary Education Income Support Child Welfare Mental Health Developmental Disabilities Public Safety Workforce 8
  • 9. Little Spent on Prevention/Treatment 4.4% of Federal and State Substance-Related Spending Is in the Familiar Categories of: • • Treatment • Research • Regulation and Compliance • © CASAColumbia 2013 Prevention Interdiction 9
  • 10. The Substance Abuse/Addiction Dollar Of every Federal and State $ spent in 2005: Research 0.4 cents Prevention/Treatment 1.9 cents Regulation/Compliance 1.4 cents Interdiction 0.7 cents Burden to Public Programs 95.6 cents Of every dollar federal and state governments spent on prevention and treatment, they spent $59.83 in public programs shoveling up the wreckage of alcohol, tobacco and other drugs--despite evidence of cost-effective sciencebased interventions. © CASAColumbia 2013 10
  • 11. Conservative Estimates • Examples of costs unavailable due to data limits:  Higher education  Tobacco/drug-related developmental disabilities  Drug-related highway accidents  Civil court costs  Many local government costs © CASAColumbia 2013 11
  • 12. Total Spending If spending on substance abuse and addiction were its own budget category: • It would rank 2nd at the state level, behind elementary and secondary education • It would rank 6th at the federal level, behind social security, national defense, income security, Medicare and other health programs including the federal share of Medicaid © CASAColumbia 2013 12
  • 13. Spending just on the burden of substance abuse and addiction takes at least $1,486 each year from every man, woman and child in America-$5,944 from a family of four © CASAColumbia 2013 13
  • 14. Greatest Burden in Two Areas Of Federal and State 2005 Burden Spending of $357.4 billion, 71.1% Is in Health Care and Justice System Costs • 58.0% of burden is in health care costs – substance abuse and addiction that cause or contribute to more than 70 other diseases requiring hospitalization • 13.1% of burden is in justice system costs – substance abuse that drives crime, incarceration and recidivism © CASAColumbia 2013 14
  • 15. Federal Burden Spending Burden of Substance Abuse and Addiction on Federal Programs by Budget Sector (Percent) Total = $229.9 Billion Mental Health/ Developmental Disabilities 1.6 Public Safety 3.3 Federal Workforce 0.4 Justice System 2.4 Child/Family Assistance 16.0 Education 2.4 Health Care 74.1 © CASAColumbia 2013 15
  • 16. State Burden Spending Burden of Substance Abuse and Addiction on State Programs by Budget Sector (Percent) Total = $127.5 Billion Mental Health/ Developmental Disabilities 6.4 Child/Family Assistance 7.8 Public Safety 1.4 Federal Workforce 0.5 Justice System 32.5 Education 22.4 Health Care 29.0 © CASAColumbia 2013 16
  • 17. Local Burden Spending Burden of Substance Abuse and Addiction on Local Programs by Budget Sector (Percent) Total = $93.3 Billion Public Safety 13.7 Local Workforce 1.5 Justice System 29.2 Child/Family Assistance 8.2 Education 24.4% Health Care 23.0 © CASAColumbia 2013 17
  • 18. Federal and State Burden Spending (2005) Health Care Justice System Child/Family Assistance Education Mental Health/DD Public Safety Workforce TOTAL © CASAColumbia 2013 ($ millions) 207,222 46,977 46,696 33,896 11,772 9,303 1,568 357,433 18
  • 19. Other Federal and State Spending (2005) Little Spent in Familiar Substance Abuse and Addiction Categories: Prevention and Treatment ($ millions) 7,173 Research 1,604 Regulation and Compliance 5,066 Interdiction 2,638 TOTAL © CASAColumbia 2013 16,481 19
  • 20. Sin Taxes Don’t Pay Their Way For each $ federal and state governments collect in alcohol and tobacco taxes and liquor store revenues, they spend $8.95 shoveling up the consequences • The public health goal of tobacco taxes: eliminate use • The public health goal of alcohol taxes: limit underage and adult excessive drinking © CASAColumbia 2013 20
  • 21. For Every $100 Spent On Substance Abuse and Addiction Government Prevention, Treatment and Research Federal $ 2.33 State Average $ 2.38 Wide Variation: Connecticut $10.39 Kentucky Hawaii $ 7.32 $ 0.55 New Hampshire $ 0.22 © CASAColumbia 2013 21
  • 22. RECOMMENDATIONS • Prevention • Treatment/Disease Management • Taxation and Regulation • Research © CASAColumbia 2013 22
  • 23. Prevent It! • Public health information campaign • Comprehensive messages and programs aimed at children • Screenings, brief interventions and treatment referrals © CASAColumbia 2013 23
  • 24. Treat It! • Comprehensive assessments • Behavioral and pharmacological treatments • Treatments for co-occurring disorders • Long term disease management • Drug treatment alternatives to prison and prison-based treatment and aftercare • Health insurance coverage for addiction prevention and treatments © CASAColumbia 2013 24
  • 25. Control It! • Alcohol and tobacco tax increases • Indoor smoking bans and tobacco quit lines • Increased enforcement to limit youth access to tobacco and alcohol © CASAColumbia 2013 25
  • 26. Understand It! • Increased genetic, biological and behavioral research • Best practices • Cost/benefit studies © CASAColumbia 2013 26
  • 27. Addiction is a disease that should be prevented and treated--rather than waiting for the disease to advance, cause enormous human suffering and drive up health care, corrections and other social costs © CASAColumbia 2013 27
  • 29. Speaker Notes Slide 1: • This is the first study ever conducted documenting the costs of substance abuse and addiction to all levels of government. Slide 2: • • • • This report is an update of CASAColumbia’s 2001 report of the same name that documented costs of substance abuse to state governments. This study was conducted in response to multiple requests from the states for updated state data. We also extended the analysis to the federal and local levels. This report breaks down substance related spending to look at: 1. How much goes to carry the burden of substance abuse and addiction in public programs. By burden we mean the costs that governments incur to deal with the consequences of our failure to prevent or treat the problem--consequences that drive up costs, for example, of health care, crime, child neglect and abuse, and even workforce spending. 2. And how much of it goes to the familiar categories of substance related spending: prevention, treatment, research, taxation, regulation, and drug interdiction. Finally, the report identifies many promising and cost effective investment options. Slide 6: • Of the $4.4 trillion in total federal, state and local government spending in 2005, at least $467.7 billion (10.7% of total spending) went to deal with substance abuse and addiction. © CASAColumbia 2013 29
  • 30. Speaker Notes Slide 8: • The most shocking finding is that 95.6% of total substance-related federal and state spending goes to shovel up the burden of this health problem in the budget categories you see here. Slide 9: • • Only 4.4% of state and federal spending is divided among these more familiar categories. This report is a searing indictment of the policies of government at every level that spend virtually all of the funds in this area to shovel up the wreckage of substance abuse and addiction and relatively little to prevent and treat it. Slide 10: • • Here you can see how the burden to public programs at the federal and state level consumes our resources. Less than 2 cents of every substance abuse dollar goes to prevention and treatment, despite extensive evidence of cost-effective strategies. © CASAColumbia 2013 30
  • 31. Speaker Notes Slide 11: • • • • Despite the enormity of spending in this area, these estimates are in every measure conservative: In cases where our data were limited, we always chose the conservative estimate. In some areas, such as you see here, we were not able to make any estimates due to data limitations. The true costs to government are likely much higher than our estimates suggest. Slide 12: • Even with these conservative assumptions, • If spending on tobacco, alcohol and other drugs were its own state budget category, it would rank second, surpassed only by state spending on elementary and secondary education. • At the federal level, it would rank 6th behind the big ticket items like social security, national defense and health. Slide 13: • Total government substance-related spending on the burden to public programs amounts to an average of $1,486 each year for every person in America--almost $6,000 for a family of 4. © CASAColumbia 2013 31
  • 32. Speaker Notes Slide 14: • • Two areas of spending on the burden of substance abuse and addiction to government comprise almost 3/4 of federal and state burden spending: health care and the justice system. The largest share is the impact on health spending where untreated addiction drives hospitalizations for more than 70 other diseases. Slide 15: • • • • With these next 3 slides, you will see how the burden to public programs is distributed at each level of government. This is the 95.6 cents of every substance abuse dollar. At the federal level, spending on the burden of this disease in our health care programs consumes 74% of federal burden spending. The next largest category is child and family assistance--welfare and services for children who are neglected and abused. Slide 16: • • At the state level, justice system spending makes up the largest share of the burden, Followed closely by health care and the cost of substance abuse to the education system—such as special education for those with substance-related learning disabilities or mental retardation. © CASAColumbia 2013 32
  • 33. Speaker Notes Slide 17: • • As with the states, substance-related justice spending is the largest share of local burden spending. Substance-related education spending comes in second locally, followed closely by health care. Slide 18: • • Here is a summary of how the federal and state burden spending breaks out by category. Health care spending dwarfs all other categories. Slide 19: • Here is the same information for the remaining categories of spending. © CASAColumbia 2013 33
  • 34. Speaker Notes Slide 20: • • Tobacco and alcohol taxes reduce use and provide much needed government revenues--but these taxes don’t begin to offset the burden substance abuse imposes. For each dollar federal and state governments receive in tobacco and alcohol taxes and liquor store revenues, they pay almost $9 on the burden of substance abuse. Slide 21: • • • Even though spending on prevention, treatment and research is very low, there are wide variations among the states. For every $100 in substance-related spending, • The federal government spends $2.33 on prevention, treatment and research • And states spend on average about the same--$2.38 But spending ranges from a low of: • $0.22 in New Hampshire • To a high of $10.39 in Connecticut © CASAColumbia 2013 34
  • 35. Speaker Notes Slide 22: • • There is much more detail in the report on substance-related spending by jurisdiction, and a wide range of recommendations. Key recommendations are designed to reverse our upside down spending patterns. Slide 23: • • • Prevention is a top priority and the main focus of our prevention efforts must be our children. Prevention strategies should include broad-based public health information campaigns to: • Increase public understanding about addiction, and • Change the culture around alcohol and other drug use as we have done with tobacco. Examples are: • Targeted media campaigns like the Legacy’s truth campaign • Comprehensive school and community-based programs • And screenings and brief interventions in many different venues to look for the problem and intervene early before the disease and its cost progress. © CASAColumbia 2013 35
  • 36. Speaker Notes Slide 24: • • • • • Effective evidence-based treatment is critical. Approximately 9% of the population suffers from an addictive disorder, but only about 10% of them receive treatment--lower than for any other health condition. Treatment includes: • Behavioral and pharmacological approaches • Treatment for mental and other health disorders that co-occur with addiction • And long term disease management as would be provided for diabetes and hypertension, for example. Health insurance coverage for early intervention and treatment, as we do with other chronic diseases, is essential--as is expanded coverage for the uninsured. A review of the cost-related research on treatment by the National Institute on Drug Abuse found that investments in treatment alone could yield a savings of $12 or more for every dollar invested. © CASAColumbia 2013 36
  • 37. Speaker Notes Slide 25: • • • • We need to do a better job of regulation and control. Taxation on tobacco can help reduce smoking and on alcohol can curb both underage and adult excessive drinking. Raising alcohol and tobacco taxes also are linked to immediate health and cost benefits as are indoor smoking bans And increased enforcement can help keep these substances out of the hands of children and teens. Slide 26: • We need to increase our knowledge about the disease of addiction and more cost-effective prevention and treatment options. © CASAColumbia 2013 37
  • 38. Speaker Notes Slide 27: • • • • Medical science has demonstrated that addiction is a disease that can and should be prevented and treated. America’s failure to recognize this fact has resulted in untold and avoidable human suffering as well as the billions in wasted spending this report has uncovered. The findings of this report suggest a huge opportunity for costs savings--savings that are particularly crucial in these times of tight budget constraints. The shifts in investments we recommend do not all require new money. We need to change the way we do business--for example, paying for treatment and training instead of simply incarceration. Because there is no broad-based implementation plan in place, we can’t put a definitive price on expected savings. We do know, though, that specific interventions can yield significant returns in a short period. For example: • Screenings and brief interventions can reduce hospitalizations by up to 37% and ER visits by up to 20% in a year • Treatment can reduce alcohol- or other drug-related medical visits by more than 1/2 in a year • A 10% increase in cigarette taxes can reduce youth smoking by 6-7%. And we know that the impact is likely compounded as more and more interventions are taken to scale. © CASAColumbia 2013 38